AXL signaling in cancer: from molecular insights to targeted therapies is a research paper published in Signal Transduction and Targeted Therapy (2025). On theSindex it has a DataRank of 0. It has been cited 69 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Dana-Farber/Harvard Cancer Center
Grant: 5P50CA101942-18
DF/HCC Kidney Cancer SPORE
Dana-Farber/Harvard Cancer Center
Grant: 2P50CA101942-16 and 5P30CA006516-56
Foundation for the National Institutes of Health
Grant: RO1 CA193675 and RO1 CA222355
NCI NIH HHS
Grant: P50 CA101942
NCI NIH HHS
Grant: R01 CA193675
NCI NIH HHS
Grant: R01 CA222355
NCI NIH HHS
Grant: P30 CA006516
National Institutes of Health
Grant: 5P30CA006516-56
Dana-Farber/Harvard Cancer Center
National Institutes of Health
Grant: 5R01CA222355-02
Protective role of Honokiol in preventing c-Met-induced post-transplantation cancer
National Institutes of Health
Grant: 5R01CA193675-05
Novel Role(s) of Nrf2 in the Growth of Post-Transplantation Cancer
The Kohlberg Chair at Harvard Medical School and the Trust Family, Michael Brigham, Pan Mass Challenge, Hinda and Arthur Marcus Fund and Loker Pinard Funds for Kidney Cancer Research at DFCI
M K Bhan YRFP, Department of Biotechnology, Ministry of Science and Technology
MacNaught Fellowship
FWCI
26.95
Citation Percentile
1.0%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals